Clinical Trials / Studies Results
Search for Clinical Trials
An extension of studies to evaluate Abbv-951 in subjects with advanced Parkinson's disease (H-52937)
Abbvie Inc. - An Open-label extension of studies M15-736 and M20-339 to evaluate the safety and tolerability of 24-hour daily exposure of Abbv-951 in…
A multicenter, double-blind, placebo-controlled, randomized withdrawal study to evaluate the safety and maintenance of efficacy of ecopipam in…
The purpose of this study is to find out how safe and effective the new drug, AMX0035, is for the treatment of PSP and to determine if AMX0035 can…
A multicenter, open-label, study to evaluate the long-term safety of ecopipam tablets in children, adolescents and adults with Tourette's disorderThe…
IKT-148009-201/ A Phase 2, randomized, double-blind, placebo-controlled trial of IKT-148009 in untreated Parkinson's diseaseThe purpose of this study…
A 17-Week, Phase 2, Randomized, Double-blind, Placebo-controlled, Flexible-dosing, Parallel-group, multicenter study of the efficacy and safety of…
Multiple gestation increases the risk of preterm delivery. Babies born preterm have increased rates of neonatal mortality and long-term…
Emerging data support a link between sleep disordered breathing (SDB) and adverse pregnancy outcomes. In particular, women with obstructive sleep…
The goal is to determine whether treatment of mild chronic hypertension in pregnancy influences maternal risk of cardiovascular disease (CVD) and to…
The purpose of this study is to collect information on breast reconstruction surgeries to determine the effect of neurotization of autologous tissue…